Marco Guazzi to Follow-Up Studies
This is a "connection" page, showing publications Marco Guazzi has written about Follow-Up Studies.
Connection Strength
0.207
-
A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction. Eur J Heart Fail. 2018 07; 20(7):1115-1124.
Score: 0.047
-
Mitral regurgitation in heart failure: insights from CPET combined with exercise echocardiography. Eur Heart J Cardiovasc Imaging. 2017 Mar 01; 18(3):296-303.
Score: 0.044
-
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol. 2021 Jul; 110(7):1020-1028.
Score: 0.014
-
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years. Eur J Heart Fail. 2019 02; 21(2):208-217.
Score: 0.013
-
Dose-dependent efficacy of ß-blocker in patients with chronic heart failure and atrial fibrillation. Int J Cardiol. 2018 Dec 15; 273:141-146.
Score: 0.012
-
Clinical Outcome of Electrophysiologically Guided Ablation for Nonparoxysmal Atrial Fibrillation Using a Novel Real-Time 3-Dimensional Mapping Technique: Results From a Prospective Randomized Trial. Circ Arrhythm Electrophysiol. 2018 03; 11(3):e005904.
Score: 0.012
-
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension. Eur J Heart Fail. 2018 04; 20(4):725-734.
Score: 0.012
-
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail. 2018 04; 20(4):700-710.
Score: 0.011
-
Oxygen consumption and carbon-dioxide recovery kinetics in the prediction of coronary artery disease severity and outcome. Int J Cardiol. 2017 Dec 01; 248:39-45.
Score: 0.011
-
Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities. Am Heart J. 2017 Oct; 192:120-127.
Score: 0.011
-
Prognostic role of ß-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail. 2017 07; 19(7):904-914.
Score: 0.011
-
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10; 167(6):2710-8.
Score: 0.008